- Home
- SLDB vs SOL Comparison
SLDB vs SOL Comparison
Compare SLDB & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- SOL
- Stock Information
- Founded
- SLDB 2013
- SOL 2005
- Country
- SLDB United States
- SOL United States
- Employees
- SLDB N/A
- SOL N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- SOL Semiconductors
- Sector
- SLDB Health Care
- SOL Technology
- Exchange
- SLDB Nasdaq
- SOL Nasdaq
- Market Cap
- SLDB 124.7M
- SOL 104.0M
- IPO Year
- SLDB 2018
- SOL 2008
- Fundamental
- Price
- SLDB $3.27
- SOL $2.04
- Analyst Decision
- SLDB Strong Buy
- SOL Buy
- Analyst Count
- SLDB 12
- SOL 3
- Target Price
- SLDB $17.75
- SOL $3.83
- AVG Volume (30 Days)
- SLDB 565.4K
- SOL 277.9K
- Earning Date
- SLDB 03-12-2025
- SOL 11-14-2024
- Dividend Yield
- SLDB N/A
- SOL N/A
- EPS Growth
- SLDB N/A
- SOL N/A
- EPS
- SLDB N/A
- SOL N/A
- Revenue
- SLDB N/A
- SOL $102,489,000.00
- Revenue This Year
- SLDB N/A
- SOL N/A
- Revenue Next Year
- SLDB N/A
- SOL $46.42
- P/E Ratio
- SLDB N/A
- SOL N/A
- Revenue Growth
- SLDB N/A
- SOL 25.98
- 52 Week Low
- SLDB $3.03
- SOL $1.41
- 52 Week High
- SLDB $15.05
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- SLDB 31.17
- SOL 51.14
- Support Level
- SLDB $3.03
- SOL $1.86
- Resistance Level
- SLDB $4.59
- SOL $2.17
- Average True Range (ATR)
- SLDB 0.32
- SOL 0.14
- MACD
- SLDB -0.04
- SOL 0.00
- Stochastic Oscillator
- SLDB 15.38
- SOL 40.91
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.